- The trend backdrop is active with a 25-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
CL
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
Colgate-Palmolive Company · Consumer Defensive · Household & Personal Products
Latest close
90.75 USD
-1.8%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 2.4% above the Trend Line and sits at 68.3% of its 52-week range. The latest completed week returned -1.8%, after a -0.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 45/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 1d.
Setup score
58
out of 100
Latest Close
90.75 USD
24 Jul 2026
1W Return
-1.8%
latest completed week
4W Return
-0.9%
short-term follow-through
12W Return
4.0%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.8%
Latest completed week; four-week move -0.9%.
Indicator stack
71/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 60.60%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
45/100 conviction; expected move 4.3%.
News sentiment
57/100
21 relevant articles in the latest sentiment read.
Event risk
1d
Next report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 2.4% above the Trend Line and sits at 68.3% of its 52-week range. The latest completed week returned -1.8%, after a -0.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7612-week average 0.55
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.76Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.9% over four weeks, 4.0% over 12 weeks, and 5.2% over one year. The current trend has remained active for 25 consecutive weeks.
Performance by holding period
Active trend streak25 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.51Latest activity-pressure read.
Pressure change154.0%Four-week change in activity pressure.
Leadership-0.84Latest relative-leadership reading.
RS change-335.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 97%
Model confidence 93%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality98/100Profitability and accounting quality. Underlying universe rank 3; rank 1 is best.
Momentum31/100Medium-term price momentum. Underlying universe rank 70; rank 1 is best.
Growth5/100Revenue and earnings growth. Underlying universe rank 96; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 34.8x Price divided by trailing earnings.
- Price / sales
- 3.5x Market value relative to trailing revenue.
- EV / EBITDA
- 20.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 6.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 60.1% Gross profit retained from each unit of revenue.
- Operating margin
- 15.6% Operating profit retained from revenue.
- Free-cash-flow margin
- 23.7% Free cash flow generated from revenue.
- Return on invested capital
- 35.4% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 4.3% Latest one-year revenue growth.
- EPS growth
- -28.0% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 7.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 2.3% Cash dividends relative to market value.
- Buyback yield
- 1.4% Net share repurchases relative to market value.
- Shareholder yield
- 3.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
CL shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.57, expected move of 4.3%, and Sharemaestro trend signal active.
Conviction45/100
Expected move4.3%
Put/call volume0.57
Insider activity18 / 2
18 acquisitions and 2 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment57/100
Weighted news tone is neutral across 21 relevant articles.
10 positive · 10 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings1dNext report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
Options expected move4.3%Nearest-chain priced movement where available.
52-week drawdown-8.1%Distance below the 52-week high.
13-week volatility2.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher14 of 2612 weeks finished lower.
Best week+4.6%Week of 6 Feb.
Worst week-5.6%Week of 6 Mar.
Latest week-1.8%Week of 24 Jul.
Shape of recent returns
Strong gains3
Modest gains11
Flat weeks0
Modest losses9
Sharp losses3
Recent vol2.0%13-week weekly-return volatility.
Base vol2.6%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew2.2% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Consumer Defensive
4-week rank50 / 100
Group average-0.3%
Trend breadth49.0%
Trend49.0%active weekly trend signals
MD58.0%positive activity pressure
RS33.0%positive relative leadership
Four-week leaders
IndustryUS Household & Personal Products
4-week rank23 / 28
Group average4.4%
Trend breadth39.3%
Trend39.3%active weekly trend signals
MD85.7%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape60/100
Trend, activity pressure, participation, and risk combine to a 60/100 tape read.
Indicator analysis61/100Latest 12-week confirmation: trend 12/12, activity pressure 5/12, relative leadership 3/12.
Activity pressure 0.76; No reversal markers Next-Week ExpectancyPositive 60.60%Next-week expectancy is positive with a 60.60% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors41/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 27 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options61/100CL shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.57, expected move of 4.3%, and Sharemaestro trend signal active.
Bullish · Call-side pressure · Expected move 4.3% Sentiment57/100Weighted news tone is neutral across 21 relevant articles.
Colgate-Palmolive Company $CL Stake Lowered by Evelyn Partners Asset Management Ltd Insiders18 / 218 acquisitions and 2 disposals in the latest 180-day insider tape.
Earnings1dNext report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 90.75 USD | -1.8% | 88.63 USD | 84.95 USD | 0.51 | -0.84 | 21.8M | On |
| 17 Jul 2026 | 92.45 USD | 0.8% | 88.23 USD | 84.83 USD | 0.73 | 0.20 | 18.9M | On |
| 10 Jul 2026 | 91.71 USD | -3.0% | 87.73 USD | 84.70 USD | 0.72 | -2.32 | 24.0M | On |
| 3 Jul 2026 | 94.58 USD | 3.3% | 87.25 USD | 84.57 USD | 0.48 | 1.80 | 16.8M | On |
| 26 Jun 2026 | 91.54 USD | 2.9% | 86.67 USD | 84.41 USD | 0.20 | 0.36 | 29.9M | On |
| 19 Jun 2026 | 88.97 USD | -0.5% | 86.27 USD | 84.29 USD | -0.22 | -5.03 | 28.4M | On |
| 12 Jun 2026 | 89.45 USD | 1.0% | 85.97 USD | 84.18 USD | -0.44 | -4.02 | 24.5M | On |
| 5 Jun 2026 | 88.58 USD | -1.7% | 85.55 USD | 84.07 USD | -0.53 | -4.82 | 29.6M | On |
| 29 May 2026 | 90.13 USD | -0.5% | 85.19 USD | 83.95 USD | -0.62 | -5.99 | 20.0M | On |
| 22 May 2026 | 90.61 USD | 2.8% | 84.73 USD | 83.83 USD | -0.58 | -4.64 | 25.7M | On |
| 15 May 2026 | 88.13 USD | 0.7% | 84.27 USD | 83.70 USD | -0.64 | -6.95 | 25.5M | On |
| 8 May 2026 | 87.55 USD | 0.3% | 83.94 USD | 83.62 USD | -0.61 | -7.81 | 25.0M | On |
| 1 May 2026 | 87.26 USD | 3.1% | 83.57 USD | 83.54 USD | -0.62 | -6.49 | 30.7M | On |
| 24 Apr 2026 | 84.65 USD | -0.7% | 83.21 USD | 83.47 USD | -0.61 | -8.93 | 25.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.